All In Biotech

Drug Trial Radar · NCT04573023

A Phase III Study of JR-141 in Patients With Mucopolysaccharidosis II (STARLIGHT)

Last checked: Nov 20, 2026Latest source record: Oct 2, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

86

Actual

Start

Feb 14, 2022

Primary completion

Oct 31, 2027

Study completion Oct 31, 2027

Sponsor

Lead sponsor
JCR Pharmaceuticals Co., Ltd.Industry
Sponsor type
Industry
First posted
Oct 5, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Global Phase III multicenter, randomized, assessor-blinded, active-controlled designed to evaluate safety and efficacy of study drug for the treatment of the MPS II.

Conditions

  • Mucopolysaccharidosis II

Interventions

  • JR-141Drug

    IV infusion, 2.0 mg/kg/week

  • IdursulfaseDrug

    IV infusion

  • JR-141 or IdursulfaseDrug

    The subjects who have achieved the pre-specified criteria\* are able to change the drug. \*If a subject in Idursulfase group shows decline in their neurocognitive outcome, idursulfase can be switched to JR-141. If a subject in JR-141 group shows decline in their peripheral outcome, JR-141 will be switched to idursulfase.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in levels of cerebrospinal fluid heparan sulfate from baseline (Cohort A)Time frame: Baseline to Week 53
  2. Change in the raw scores of cognitive testing measured from baseline (BSID-III) (Cohort A)Time frame: Baseline to Week 105

Locations

26 sites in 12 countries. Site status is shown where the registry gives one.

  • Phoenix Children's Hospital

    Phoenix, Arizona

  • UCSF Benioff Children's Hospital Oakland

    Oakland, California

  • Ann & Robert H. Lurie Children's Hospital of Chicago

    Chicago, Illinois

  • University of Minnesota

    Minneapolis, Minnesota

  • Columbia University Irving Medical Center

    New York, New York

  • University of North Carolina at Chapel Hill Medical School Wing E

    Chapel Hill, North Carolina

  • Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania

  • Hospital Universitario Austral

    Buenos Aires, Argentina

  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Brazil

  • Instituto de Genética e Erros Inatos do Metabolismo

    São Paulo, Brazil

  • Fundación Cardio Infantil - Instituto de Cardiología

    Bogotá, Colombia

  • Hôpital Femme Mère Enfant

    Lyon, France

  • Chu De Montpellier Hopital Gui De Chauliac

    Montpellier, France

  • Hôpital Armand Trousseau

    Paris, France

  • Universitätsklinikum Giessen

    Giessen, Germany

  • Universitätsklinikum Hamburg-Eppendorf

    Hamburg, Germany

  • SphinCS GmbH

    Höchheim, Germany

  • Universitätsmedizin Mainz

    Mainz, Germany

  • Clalit Health Services Ha'Emek Medical Center

    Afula, Israel

  • Sheba Medical Center

    Ramat Gan, Israel

  • Osp. Pediatrico Bambino Gesù, IRCCS

    Rome, Italy

  • Uniwersytecki Szpital Dziecięcy

    Krakow, Poland

  • Hospital Sant Joan de Déu

    Barcelona, Spain

  • Gazi University Medicine Faculty Hospital

    Ankara, Turkey (Türkiye)

  • Ege University Children Hospital

    Izmir, Turkey (Türkiye)

  • Great Ormond Street Hospital for Children NHS Trust - Metabolic Medicine

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.